US2005186645A1PendingUtilityA1
Method for analyzing a glycomolecule
Priority: Dec 18, 2003Filed: Dec 20, 2004Published: Aug 25, 2005
Est. expiryDec 18, 2023(expired)· nominal 20-yr term from priority
Inventors:Yehudit AmorOfer MarkmanMirit Kolog GulkoAlbena SamokovliskyFredi KleinmanTal AlergandRakefet RosenfeldRuth MayaSabina RebeIdil Kelson KasutoHaim Bangio
G01N 33/5308G01N 2333/924G01N 2400/02G01N 2333/42
33
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates generally the structural analysis of glycomolecule-containing macromolecules, such as those that occur either attached to proteins (proteoglycans, glycoproteins), lipids, or as free saccharides.
Claims
exact text as granted — not AI-modified1 . A method for determining a glycomolecule fingerprint for a glycomolecule, the method comprising:
providing a glycomolecule, wherein said glycomolecule has been modified by desialylation or treatment with N-Glycosidase F (PNGaseF); adding said glycomolecule to a substrate comprising a plurality of saccharide-binding agents; detecting glycomolecule bound to saccharide-binding agents in the plurality; and obtaining a fingerprint for the glycomolecule based on the binding of the glycomolecule to the saccharide-binding agents.
2 . The method of claim 1 , wherein said glycomolecule been modified by desialylation.
3 . The method of claim 2 , wherein substantially all of the sialic acid residues have been removed from said glycomolecule.
4 . The method of claim 2 , wherein the desialylation is effected by reacting said glycomolecule with a sialidase.
5 . The method of claim 4 , wherein said glycomolecule is reacted with said sialidase in the presence of a protease inhibitor.
6 . The method of claim 1 , wherein said glycomolecule been modified by treatment with PNGaseF.
7 . The method of claim 6 , wherein substantially all of Asn-acetylglucosamine bonds have been cleaved in said glycomolecule by said PNGaseF.
8 . The method of claim 1 , wherein said glycomolecule been modified by desialylation and treatment with PNGaseF.
9 . The method of claim 1 , further comprising reacting said glycomolecule with a reducing agent and an alkylating agent prior to obtaining said fingerprint.
10 . The method of claim 9 , wherein said glycomolecule been modified by desialylation.
11 . The method of claim 10 , wherein said method comprises reacting said glycomolecule with said reducing agent and alkylating agent following desialylation.
12 . The method of claim 9 , wherein said reducing agent is selected from the group consisting of β-mercaptoethanol, dithiothreitol, and mercaptethylamine.
13 . The method of claim 9 , wherein said alkylating agent selected from the group consisting of iodoacetamide and iodoacetic acid.
14 . The method of claim 1 , wherein all steps of said method are performed in a single container.
15 . The method of claim 1 , glycomolecule is detected with a label associated with said glycomolecule.
16 . The method of claim 15 , wherein said label is a fluorescent label.
17 . The method of claim 16 , wherein said fluorescent label is selected from the group consisting of fluorescein isothiocyanate (FITC), rhodamine, Texas Red, and Cy5.
18 . The method of claim 15 , wherein said label is added to said glycomolecule prior to adding said glycomolecule to said substrate.
19 . The method of claim 15 , wherein said label is added to glycomolecule after adding said glycomolecule to said substrate.
20 . The method of claim 15 , wherein said label is added to glycomolecule while adding said glycomolecule to said substrate.
21 . The method of claim 15 , wherein said label is associated directly with said glycomolecule.
22 . The method of claim 15 , wherein said label is associated with a second saccharide-binding agent that binds to said glycomolecule.
23 . The method of claim 22 , wherein said second saccharide-binding agent is a lectin.
24 . The method of claim 22 , wherein said second saccharide-binding agent is an antibody.
25 . The method of claim 1 , further comprising purifying said glycomolecule prior to adding said glycomolecule to said substrate.
26 . The method of claim 25 , wherein said purification is by column chromatography.
27 . The method of claim 1 , wherein said glycomolecule is a glycoprotein.
28 . The method of claim 27 , wherein said glycoprotein is from a cell culture medium.
29 . The method of claim 27 , wherein said glycoprotein includes at least a portion of an immunoglobulin polypeptide.
30 . The method of claim 29 , wherein said immunoglobulin in IgG isotype.
31 . The method of claim 29 , wherein said portion comprises an Fc molecule.
32 . The method of claim 1 , wherein said method comprsies treating said glycomolecule with a detergent prior to obtaining said fingerprint.
33 . The method of claim 32 , wherein said detergent is an ionic detergent.
34 . The method of claim 33 , wherein said detergent is sodium docecyl sulfate (SDS).
35 . The method of claim 1 , wherein said substrate is a microsphere.
36 . The method of claim 35 , wherein said substrate comprises a plurality of micropsheres.
37 . The method of claim 35 , wherein no more than one type of saccharide-binding agent is present on said microsphere.
38 . The method of claim 35 , wherein more than one type of saccharide-binding agent is present on said microsphere.
39 . A method for determining a glycomolecule fingerprint for a glycomolecule, the method comprising:
adding a glycomolecule to a substrate comprising a plurality of saccharide-binding agents; detecting glycomolecule bound to saccharide-binding agents in the plurality; and obtaining a fingerprint for the glycomolecule based on the binding of the glycomolecule to the saccharide-binding agents.
40 . The method of claim 15 , wherein said glycomolecule is associated with a label, and bound glycomolecules are detected by identifying bound label on said substrate.
41 . The method of claim 40 , label is a fluorescent label.
42 . The method of claim 41 , wherein said fluorescent label is selected from the group consisting of fluorescein isothiocyanate (FITC), rhodamine, Texas Red, and Cy5.
43 . The method of claim 40 , wherein said label is added to said glycomolecule prior to adding said glycomolecule to said substrate.
44 . The method of claim 40 , wherein said label is added to glycomolecule after adding said glycomolecule to said substrate.
45 . The method of claim 40 , wherein said label is added to glycomolecule while adding said glycomolecule to said substrate.
46 . The method of claim 40 , wherein said label is associated directly with said glycomolecule.
47 . The method of claim 40 , wherein said label is associated with a second saccharide-binding agent that binds to said glycomolecule.
48 . The method of claim 47 , wherein said second saccharide-binding agent is a lectin.
49 . The method of claim 47 , wherein said second saccharide-binding agent is an antibody.
50 . The method of claim 40 , wherein said label is associated with an agent that binds to a non-carbohydrate molecule on said glycomolecule.
51 . The method of claim 50 , wherein said glycomolecule is a glycoprotein and said agent binds to a peptide epitope on said glycoprotein.
52 . The method of claim 49 , wherien said substrate is substantially planar.
53 . The method of claim 40 , wherien said substrate is a microsphere.
54 . The method of claim 53 , wherein said substrate comprises a plurality of micropsheres.
55 . The method of claim 53 , wherein each microsphere comprises one type of saccharide binding agent.
56 . A kit for analyzing a glycomolecule, the kit comprising
a glycomolecule modification agent selected from the group consisting of a desialidase and a PNGase F; and a labeling agent for labeling a glycomolecule.
57 . The kit of claim 56 , further comprising a substrate comprising a plurality of saccharide-binding agents.
58 . The kit of claim 56 , further comprising a reducing agent and an alkylating agent.
59 . The kit of claim 56 , wherein said labeling agent binds directly to a glycomolecule.
60 . The kit of claim 56 , wherein said labeling agent comprises a second saccharide-binding agent and a label that associates with said second saccharide-binding agent.
61 . The kit of claim 56 , further comprising a substrate holder.
62 . A kit for analyzing a glycomolecule, the kit comprising
an antibody specifically binds to a glycoprotein; and a labeling agent for labeling a glycomolecule.
63 . The kit of claim 62 , further comprising a glycomolecule modification agent selected from the group consisting of a desialidase and a PNGase F.
64 . The kit of claim 62 , further comprising a substrate comprising a plurality of saccharide-binding agents.
65 . The kit of claim 62 , further comprising a reducing agent and an alkylating agent.
66 . The kit of claim 62 , wherein said labeling agent binds directly to a glycomolecule.
67 . The kit of claim 62 , wherein said labeling agent comprises a second saccharide-binding agent and a label that associates with said second saccharide-binding agent.
68 . The kit of claim 62 , further comprising a substrate holder.
69 . The kit of claim 62 , wherein said antibody binds to a polypeptide epitope on said glycoprotein.
70 . The kit of claim 62 , wherein said antibody binds to a polysaccharide epitope on said glycoprotein.Join the waitlist — get patent alerts
Track US2005186645A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.